SP Gonadotropin 1000 IU SP Laboratories

Characteristics of the drug

The use of steroids is often accompanied by the appearance of side effects and dysfunctions in the body. Many can increase the risk of developing gynecomastia, and also reduce sexual desire, libido and cause hormonal imbalances. To avoid all this, you can also use the drug SP Gonadotropin 1000 IU SP Laboratories after a course of steroids. Below you can study the characteristics of the tool, the main properties.

Information about SP Gonadotropin 1000 IU SP Laboratories

Gonadotropin 1000 IU refers to an aromatase inhibitor, its use helps to suppress the negative effects that develop when taking steroids. The tool is in demand in bodybuilding, athletes often use it during rehabilitation therapy after steroids.

Reviews about Gonadotropin 1000 IU are positive. Athletes confirm that the drug works very well. It restores hormone levels, improves sexual functions, potency, increases endurance and strength. And also improves the appearance of the body, promotes the growth of muscle tissue.

Form of release, packaging and composition

Form of release of the drug Gonadotropin 1000 IUI – injections. The package contains two ampoules with white powder and water for injection, a solution for injection is diluted from these components.

Manufacturer: SP Laboratories.

Gonadotropin 1000 IU Gonadotropin Injections SP Laboratories may have the following components:

• The active substance is chorionic gonadotropin;
• Auxiliary elements.

The medicinal product is available as a white lyophilised powder in an ampoule. The package contains a solution to dilute the powder to the state of a solution, which is administered by injection.

Course of administration and dosage

At the initial stage, it is worth studying the instructions that apply to the drug. The degree of effectiveness depends on compliance with all recommendations and rules. In addition, you can contact a specialist, he will be able to choose the best option of use, dosage, depending on the individual characteristics of the athlete’s body.

Dosage of Gonadotropin 1000 IU Laboratories SP should be 250-500 IU, administered twice a week. The course of Gonadotropin 1000 IU Laboratories SP can last up to 6 weeks.

Pharmacological action of SP Gonadotropin 1000 IU SP Laboratories

Before buying Gonadotropin 1000 IU it is recommended to consider its main properties and pharmacological actions. It is they that influence the speed and severity of the required results.

Gonadotropin 1000 IU is an aromatase inhibitor. This tool should be used as part of rehabilitation therapy after a course of strong steroids. It minimises the negative consequences, maintains the healthy state of the athlete. When used, there is a high protection against muscle mass degradation, testicular atrophy and testosterone decrease are prevented.

Gonadotropin 1000 IU has a number of positive effects:

• It restores hormone levels;
• It prevents negative consequences after a course of steroids;
• Normalises the functioning of the organs of the reproductive system;
• Increases libido;
• Improves potency, erection;
• Burns fat deposits;
• Improves the appearance of the body;
• Makes muscles toned and elastic;
• Strengthens bones and joints.

Possible side effects of taking. Overdose

During the use of the remedy side effects of gonadotropin 1000 IU appear only in rare cases. Unpleasant symptoms may occur if the dosage regimen is violated, if doses are exceeded.

Sometimes, during the use of the drug Gonadotropin 1000 IU, the following unpleasant conditions may occur:

• Pain and redness in the injection area;
• Allergic reactions;
• Pain in joints, muscles;
• Swelling;
• Rashes on the body;
• Headache;
• Sleep disturbance.

Storage conditions of the medicinal product and expiry date

Injections Gonadotropin 1000IUI is recommended to store in a cool place. The tool perfectly retains the basic properties, useful actions in the refrigerator at a temperature of +2 to +6 degrees. The storage period is – no more than 2 years. It should be stored in a blister, it is better to place it in a cardboard box.

Buy SP Gonadotropin 1000 IU SP Laboratories online in the United Kingdom

If you are looking for an original and high quality steroid remedy, you can visit our website. Buy Gonadotropin 1000 IU SP Laboratories in the United Kingdom at an affordable price you can in our online shop, selling only proven medications that have passed the necessary checks. Order Gonadotropin 1000 IU SP Laboratories with all documents and certificates, delivery is made throughout the United Kingdom.

To buy Gonadotropin 1000 IU SP Laboratories on the site you must complete a special form. Indicate the number of packages, the address where you want to deliver. In the catalogue you can view information about the order, payment methods. It also contains the cost of Gonadotropin 1000 IU SP Laboratories.

List of references

1. Fauser, B. C., Devroey, P., & Macklon, N. S. (2005). Multiple Births Resulting from Ovarian Stimulation for Subfertility Treatment. The Lancet, 365(9473), 1807-1816.
2. Balen, A. H., Laven, J. S., Tan, S. L., Dewailly, D., & Jacobs, H. S. (2003). Miscarriage Rates Following IVF Are Increased in Women with Polycystic Ovary Syndrome and Reduced by Pituitary Desensitization with Gonadotropin-releasing Hormone Agonists. Human Reproduction, 18(7), 1411-1415.
3. Popovic-Todorovic, B., Ajayi, S., Schally, A. V., Halmos, G., & Csernus, V. J. (2003). Gonadotropin-releasing Hormone Analogues Reduce Apoptosis in Various Rat Tissues in Vivo and in Cultured Pituitary Cells in Vitro. Proceedings of the National Academy of Sciences, 100(6), 3303-3308.
4. Homburg, R., Howles, C. M., & Lowenstein, L. (2003). The Role of Gonadotropin-releasing Hormone Agonists, Gonadotropins, and Embryo Toxicity in Recombinant FSH Preparations: A Review. Reproductive Biology and Endocrinology, 1(1), 111.
5. Koren, E., Zuckerman, Z., & Tzischinsky, O. (1997). Mood Changes in Adolescents During Treatment with Gonadotropin-releasing Hormone Agonists. The Journal of Clinical Endocrinology & Metabolism, 82(8), 2387-2390.